IRIDEX Corporation (IRIX)

NASDAQ: IRIX · IEX Real-Time Price · USD
-0.12 (-4.62%)
Jun 29, 2022 3:59 PM EDT - Market closed

Company Description

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders.

It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures.

The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics.

It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995.

IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIDEX Corporation
Country United States
Founded 1989
IPO Date Feb 15, 1996
Industry Health Care Equipment & Supplies
Sector Health Care
Employees 119

Contact Details

1212 Terra Bella Avenue
Mountain View, CA 94043
United States
Phone 650 940 4700

Stock Details

Ticker Symbol IRIX
Exchange NASDAQ
Fiscal Year February - January
Reporting Currency US Dollars
CIK Code 0001006045
CUSIP Number 462684101
ISIN Number US4626841013
Employer ID 77-0210467
SIC Code 3845

Key Executives

Name Position
David I. Bruce President, Chief Executive Officer and Director
Fuad Ahmad Interim Chief Financial Officer
Patrick Mercer Chief Operating Officer
Leigh Salvo Head of Investor Relations

Latest SEC Filings

Date Type Title
Jun 1, 2022 4 Statement of changes in beneficial ownership of securities
May 26, 2022 SD Specialized disclosure report
May 23, 2022 4 Statement of changes in beneficial ownership of securities
May 12, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
May 12, 2022 8-K Current report
May 3, 2022 4 Statement of changes in beneficial ownership of securities
Apr 29, 2022 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2022 DEF 14A Other definitive proxy statements
Apr 21, 2022 8-K Current report
Mar 30, 2022 4 Statement of changes in beneficial ownership of securities